Identification of a novel vardenafil analogue, 19-O-propyl hydroxy vardenafil, as a dietary supplement adulterant
Journal of Pharmaceutical and Biomedical Analysis · 2025
DOI: 10.1016/j.jpba.2024.116563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2025. Verfasst von Hui-Chun Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research and Analysis, Taiwan Food and Drug Administration, No.161-2 Kunyang St., Nangang District, Taipei City 115-61, Taiwan, ROC. Elec…. Hauptthemen laut MEDLINE: Vardenafil Dihydrochloride, Dietary Supplements, Magnetic Resonance Spectroscopy, Drug Contamination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Ministry of Health and Welfare.
Abstract (Originalsprache)
A novel vardenafil analogue was discovered during adulterant screening of a dietary supplement. After extraction and purification, this analogue was identified using liquid chromatography-high resolution mass spectrometry (LC-HRMS) and nuclear magnetic resonance (NMR) analyses. The molecular formula determined using LC-HRMS was C24H34N6O5S. Fragmentation data suggested that this unknown compound may have two modifications to vardenafil. NMR analysis confirmed the presence of a hydroxyl group on the piperazine moiety and a propyl group attached to the phenoxy group. Consequently, this compound was named 19-O-propyl hydroxy vardenafil.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Research and Analysis, Taiwan Food and Drug Administration, No.161-2 Kunyang St., Nangang District, Taipei City 115-61, Taiwan, ROC. Electronic address: huichunlee@fda.gov.tw.
- Division of Research and Analysis, Taiwan Food and Drug Administration, No.161-2 Kunyang St., Nangang District, Taipei City 115-61, Taiwan, ROC. Electronic address: yolunwu@fda.gov.tw.
- National Health Insurance Administration, Ministry of Health and Welfare, No.15-1 Gongyuan Rd., Zhongzheng District, Taipei City 100-41, Taiwan, ROC. Electronic address: B111630@nhi.gov.tw.
- Division of Research and Analysis, Taiwan Food and Drug Administration, No.161-2 Kunyang St., Nangang District, Taipei City 115-61, Taiwan, ROC. Electronic address: liyao@fda.gov.tw.
- Division of Research and Analysis, Taiwan Food and Drug Administration, No.161-2 Kunyang St., Nangang District, Taipei City 115-61, Taiwan, ROC. Electronic address: kaoamy@fda.gov.tw.
- Division of Research and Analysis, Taiwan Food and Drug Administration, No.161-2 Kunyang St., Nangang District, Taipei City 115-61, Taiwan, ROC. Electronic address: meijyhco@fda.gov.tw.
Förderung
- Ministry of Health and Welfare
Zitieren
APA
Lee, H. C., Wu, Y. L., Lin, Y. T., Tsai, L. Y., Kao, Y. M., Lin, M. C., & Tseng, S. H. (2025). Identification of a novel vardenafil analogue, 19-O-propyl hydroxy vardenafil, as a dietary supplement adulterant. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2024.116563
Vancouver
Lee HC, Wu YL, Lin YT, Tsai LY, Kao YM, Lin MC, et al. Identification of a novel vardenafil analogue, 19-O-propyl hydroxy vardenafil, as a dietary supplement adulterant. Journal of Pharmaceutical and Biomedical Analysis. 2025. doi:10.1016/j.jpba.2024.116563
BibTeX
@article{Lee2025,
author = {Lee, Hui-Chun and Wu, You-Lun and Lin, Yu-Ting and Tsai, Li-Yao and Kao, Ya-Min and Lin, Mei-Chih and Tseng, Su-Hsiang},
title = {Identification of a novel vardenafil analogue, 19-O-propyl hydroxy vardenafil, as a dietary supplement adulterant},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2025},
doi = {10.1016/j.jpba.2024.116563}
}
EUVIMED